Physician- and Patient-Reported Outcomes of the MC1635 Phase 3 Trial of Ultrahypofractionated Versus Moderately Hypofractionated Adjuvant Radiation Therapy After Breast-Conserving Surgery.
Laughlin BS, Corbin KS, Toesca DAS, Thorpe CS, Golafshar MA, Pockaj B, Cronin P, McGee LA, Halyard MY, Mutter RW, Keole SR, Park SS, Shumway DA, Vern-Gross TZ, Vallow L, Wong WW, DeWees TA, Vargas CE.
Laughlin BS, et al. Among authors: cronin p.
Int J Radiat Oncol Biol Phys. 2024 Mar 15;118(4):1049-1059. doi: 10.1016/j.ijrobp.2023.10.018. Epub 2023 Oct 31.
Int J Radiat Oncol Biol Phys. 2024.
PMID: 37914139
Free article.
Clinical Trial.